Screener
CareDx CDNA Contingent consideration
Contingent consideration at other companies
Other financials
Where this comes from
Reported directly by CareDx in its filing.
Tagged under the XBRL concept cdna:CommonStockSharesIssuedForContingentConsideration.
The source filing: CareDx’s 10-K, filed February 25, 2026. Open the filing →
- Filed
- Feb 25, 2026, 4:10 PM EST
- Fiscal year
- FY2025
- Accession
- 0001217234-26-000018
FAQ
- What is CareDx's contingent consideration?
- CareDx (CDNA) reported contingent consideration of $0 in Q4 2025.
- What is the long-term trend for CareDx's contingent consideration?
- Over 4 years (2021 to 2025), CareDx's contingent consideration has grown at a -100.0% compound annual growth rate (CAGR), from $5.34M to $0.
- What does contingent consideration mean?
- Represents the value of common stock issued to satisfy earn-out or contingent payment obligations resulting from past business acquisitions. This metric is critical for assessing the long-term cost of inorganic growth strategies and the potential dilution impact on existing shareholders.
Ask your AI about CareDx's contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude